A detailed history of Mml Investors Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 548,661 shares of ABBV stock, worth $97.9 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
548,661
Previous 537,081 2.16%
Holding current value
$97.9 Million
Previous $92.1 Million 17.62%
% of portfolio
0.39%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $1.9 Million - $2.31 Million
11,580 Added 2.16%
548,661 $108 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $3.12 Million - $3.65 Million
-20,173 Reduced 3.62%
537,081 $92.1 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $553,456 - $630,612
3,463 Added 0.63%
557,254 $101 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $10 Million - $11.3 Million
72,822 Added 15.14%
553,791 $85.8 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $1.05 Million - $1.22 Million
7,866 Added 1.66%
480,969 $71.7 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $5.42 Million - $6.74 Million
40,882 Added 9.46%
473,103 $63.7 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $5.4 Million - $6.22 Million
-37,326 Reduced 7.95%
432,221 $68.9 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $4.06 Million - $4.87 Million
29,350 Added 6.67%
469,547 $75.9 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $5.74 Million - $6.58 Million
42,753 Added 10.76%
440,197 $59.1 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $5.5 Million - $6.99 Million
39,978 Added 11.18%
397,444 $60.9 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $1.06 Million - $1.32 Million
8,053 Added 2.3%
357,466 $57.9 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $678,850 - $858,941
6,319 Added 1.84%
349,413 $47.3 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2.26 Million - $2.57 Million
21,280 Added 6.61%
343,094 $37 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $1.32 Million - $1.47 Million
12,501 Added 4.04%
321,814 $36.2 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $523,878 - $576,727
5,121 Added 1.68%
309,313 $33.5 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $2.46 Million - $3.33 Million
30,609 Added 11.19%
304,192 $32.6 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $770,440 - $904,243
8,968 Added 3.39%
273,583 $24 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $2.47 Million - $3.3 Million
33,648 Added 14.57%
264,615 $26 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $1.43 Million - $2.16 Million
22,127 Added 10.6%
230,967 $17.6 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $2.09 Million - $2.61 Million
28,961 Added 16.1%
208,840 $18.5 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $3.11 Million - $3.74 Million
-49,356 Reduced 21.53%
179,879 $13.6 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $1.51 Million - $1.92 Million
22,908 Added 11.1%
229,235 $16.7 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $2.3 Million - $2.71 Million
29,860 Added 16.92%
206,327 $16.6 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $1.74 Million - $2.15 Million
22,377 Added 14.52%
176,467 $16.3 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $3.66 Million - $4.07 Million
41,136 Added 36.42%
154,090 $14.6 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $491,994 - $582,140
5,480 Added 5.1%
112,954 $10.5 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $499,246 - $668,537
-5,426 Reduced 4.81%
107,474 $10.2 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $1.2 Million - $1.32 Million
-13,404 Reduced 10.61%
112,900 $10.9 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $8.82 Million - $11.3 Million
126,304
126,304 $11.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.